Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCompleted
NCT02890992Phase 2Updated Sep 6, 2019
Sponsor: Sanofi
Hypercholesterolaemia
United States, Canada, Czechia, France, Netherlands +5 more
Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)Completed
NCT00153803Phase 3Updated Sep 6, 2019
Sponsor: Dartmouth-Hitchcock Medical Center
Carcinoma, Non-Small-Cell Lung · Non-small Cell Lung Cancer · NSCLC
United States
Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy AdolescentsCompleted
NCT02075203Phase 2Updated Sep 4, 2019
Sponsor: Aeras
Tuberculosis
South Africa
Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)Terminated
NCT01160354Phase 1, Phase 2Updated Aug 28, 2019
Sponsor: M.D. Anderson Cancer Center
Acute Myelogenous Leukemia
United States
A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid ArthritisCompleted
NCT02287922Phase 2Updated Aug 21, 2019
Sponsor: Ablynx, a Sanofi company
Rheumatoid Arthritis
United States, Belgium, Bulgaria, Czechia, Georgia +9 more
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid ArthritisCompleted
NCT02309359Phase 2Updated Aug 21, 2019
Sponsor: Ablynx, a Sanofi company
Rheumatoid Arthritis
United States, Belgium, Bulgaria, Czechia, Georgia +9 more
Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast CancerCompleted
NCT01049425Phase 3Updated Aug 14, 2019
Sponsor: Women's Cancer Study Group GmbH
Primary Breast Cancer · Her2 Non-overexpressing
Germany
Reversing Type 1 Diabetes After it is EstablishedCompleted
NCT01106157Phase 1, Phase 2Updated Aug 5, 2019
Sponsor: University of Florida
Diabetes Mellitus, Type 1
United States
Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell CarcinomaNo Longer Available
NCT03492489N/AUpdated Aug 1, 2019
Sponsor: Regeneron Pharmaceuticals
Cutaneous Squamous Cell Carcinoma
Evaluation of ALX-0171 in Japanese Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract InfectionTerminated
NCT03418571Phase 2Updated Jul 30, 2019
Sponsor: Ablynx, a Sanofi company
Respiratory Syncytial Virus Lower Respiratory Tract Infection
Japan
An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid ArthritisCompleted
NCT02518620Phase 2Updated Jul 30, 2019
Sponsor: Ablynx, a Sanofi company
Rheumatoid Arthritis
Belgium, Bulgaria, Georgia, Germany, Hungary +7 more
A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal PolypsCompleted
NCT02912468Phase 3Updated Jul 25, 2019
Sponsor: Sanofi
Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)
United States, Bulgaria, Czechia, France, Germany +8 more
Study of a Tetravalent Dengue Vaccine in Healthy Adults in AustraliaCompleted
NCT01134263Phase 3Updated Jul 24, 2019
Sponsor: Sanofi Pasteur, a Sanofi Company
Dengue Fever · Dengue Hemorrhagic Fever
Australia
Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic DermatitisCompleted
NCT03054428Phase 3Updated Jul 23, 2019
Sponsor: Regeneron Pharmaceuticals
Moderate-to-Severe Atopic Dermatitis · Dermatitis, Dermatitis Atopic · Eczema, Skin Diseases, Skin · Diseases Genetic, Genetic
United States, Canada
To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal CancersCompleted
NCT02179970Phase 1Updated Jul 23, 2019
Sponsor: CCTU- Cancer Theme
Pancreatic Adenocarcinoma Metastatic · Ovarian Serous Adenocarcinoma · Colorectal Cancer Metastatic
United Kingdom
Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer PatientsCompleted
NCT00129376Phase 2Updated Jul 5, 2019
Sponsor: Spanish Breast Cancer Research Group
Breast Cancer
Spain
ATHENA: Natural History of Disease Study in Alport Syndrome PatientsCompleted
NCT02136862N/AUpdated Jul 2, 2019
Sponsor: Genzyme, a Sanofi Company
Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2
United States, Australia, Canada, France, Germany +1 more
Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung CancerTerminated
NCT00714246Phase 1Updated Jun 24, 2019
Sponsor: Milton S. Hershey Medical Center
Non Small Cell Lung Cancer
United States
Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or EnzalutamideTerminated
NCT02379390Phase 2Updated Jun 21, 2019
Sponsor: Sanofi
Prostate Cancer Metastatic
United States, Canada
A Study of the Effect of 20 mg Ambroxol Hydrochloride on Acute Cough.Completed
NCT03415269Phase 2Updated Jun 20, 2019
Sponsor: Hull University Teaching Hospitals NHS Trust
Cough
United Kingdom
Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the USCompleted
NCT00617344Phase 2Updated Jun 11, 2019
Sponsor: Sanofi
Dengue Fever · Dengue Hemorrhagic Fever · Dengue Virus
United States
Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate CancerCompleted
NCT01308567Phase 3Updated Jun 5, 2019
Sponsor: Sanofi
Prostate Cancer
United States, Australia, Belarus, Brazil, Canada +20 more
Safety and Efficacy of Gabapentin for Neuropathic Pain in Fabry DiseaseWithdrawn
NCT01588314Phase 2Updated May 29, 2019
Sponsor: University of Minnesota
Fabry Disease · Neuropathic Pain
United States
Peer Support in Diabetes Management - Insulin Peer SupportCompleted
NCT03437525NAUpdated May 22, 2019
Sponsor: Shanghai 6th People's Hospital
Type 2 Diabetes Treated With Insulin
China
Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy VolunteersCompleted
NCT01162486Phase 1Updated May 7, 2019
Sponsor: Johns Hopkins University
Tuberculosis · Tuberculosis, Pulmonary
United States

Previous page Next page